{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:51:30Z","timestamp":1791172290259,"version":"4.1.0"},"reference-count":74,"publisher":"Society for Neuroscience","issue":"20","license":[{"start":{"date-parts":[[2001,4,15]],"date-time":"2001-04-15T00:00:00Z","timestamp":987292800000},"content-version":"vor","delay-in-days":182,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neurosci."],"published-print":{"date-parts":[[2000,10,15]]},"abstract":"<jats:p>The striatum is the major input region of the basal ganglia, playing a pivotal role in the selection, initiation, and coordination of movement both physiologically and in pathophysiological situations such as Parkinson's disease. In the present study, we characterize interactions between NMDA receptors, adenosine receptors, and cAMP signaling within the striatum. Both NMDA (100 \u03bc<jats:sc>m<\/jats:sc>) and the adenosine A<jats:sub>2a<\/jats:sub>receptor agonist CPCA (3 \u03bc<jats:sc>m<\/jats:sc>) increased cAMP levels (218.9 \u00b1 19.9% and 395.7 \u00b1 67.2%, respectively; cf. basal). The NMDA-induced increase in cAMP was completely blocked when slices were preincubated with either the NMDA receptor antagonist 7-chlorokynurenate or the adenosine A<jats:sub>2<\/jats:sub>receptor antagonist DMPX (100 \u03bc<jats:sc>m<\/jats:sc>), suggesting that striatal NMDA receptors increase cAMP indirectly via stimulation of adenosine A<jats:sub>2a<\/jats:sub>receptors. Thus, NMDA receptors and adenosine A<jats:sub>2a<\/jats:sub>receptors might share a common signaling pathway within the striatum. In striatal slices prepared from the 6-hydroxydopamine-lesioned rat model of Parkinson's disease, NMDA receptor-mediated increases in cAMP were greater on the lesioned side compared with the unlesioned side (349.6 \u00b1 40.2% compared with 200.9 \u00b1 21.9% of basal levels, respectively). This finding substantiates previous evidence implicating overactivity of striatal NMDA receptors in parkinsonism and suggests that a common NMDA receptor\u2013adenosine A<jats:sub>2a<\/jats:sub>receptor\u2013cAMP signaling cascade might be an important mechanism responsible for mediating parkinsonian symptoms.<\/jats:p>","DOI":"10.1523\/jneurosci.20-20-07782.2000","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T02:45:48Z","timestamp":1522896348000},"page":"7782-7789","source":"Crossref","is-referenced-by-count":80,"title":["A Common Signaling Pathway for Striatal NMDA and Adenosine A<sub>2a<\/sub>Receptors: Implications for the Treatment of Parkinson's Disease"],"prefix":"10.1523","volume":"20","author":[{"given":"Joanne E.","family":"Nash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Brotchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"393","published-online":{"date-parts":[[2000,10,15]]},"reference":[{"key":"2023041302464026000_20.20.7782.1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(92)90006-N"},{"key":"2023041302464026000_20.20.7782.2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-23-09650.1998"},{"key":"2023041302464026000_20.20.7782.3","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(93)90233-2"},{"key":"2023041302464026000_20.20.7782.4","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(86)90012-6"},{"key":"2023041302464026000_20.20.7782.5","first-page":"00","article-title":"The A2a adenosine receptor antagonist KW-6002 has antiparkinsonian activity in MPTP treated cynomolgous monkeys.","volume":"13","author":"Bedard","year":"1998","journal-title":"Mov Disord"},{"key":"2023041302464026000_20.20.7782.6","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0022-3565(24)35003-7","article-title":"Differing effects of N-methyl-d-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.","volume":"290","author":"Blanchet","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"2023041302464026000_20.20.7782.7","doi-asserted-by":"publisher","DOI":"10.1038\/361031a0"},{"key":"2023041302464026000_20.20.7782.8","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"2023041302464026000_20.20.7782.9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00019052-199708000-00010","article-title":"Novel approaches to the symptomatic treatment of parkinsonian syndromes: alternatives and adjuncts to dopamine-replacement.","volume":"10","author":"Brotchie","year":"1997","journal-title":"Curr Opin Neurol"},{"key":"2023041302464026000_20.20.7782.10","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/j.1471-4159.1991.tb06436.x","article-title":"Heterogeneity of N-methyl-d-aspartate receptors regulating the release of dopamine and acetylcholine from striatal slices.","volume":"57","author":"Cai","year":"1991","journal-title":"Neurochemistry"},{"key":"2023041302464026000_20.20.7782.11","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00370-5"},{"key":"2023041302464026000_20.20.7782.12","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1983.sp014478"},{"key":"2023041302464026000_20.20.7782.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196902132800701"},{"key":"2023041302464026000_20.20.7782.14","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(93)90255-J"},{"key":"2023041302464026000_20.20.7782.15","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(94)90029-9"},{"key":"2023041302464026000_20.20.7782.16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0300-9629(89)90201-6","article-title":"Neural mechanisms in disorders of movement.","volume":"93","author":"Crossman","year":"1989","journal-title":"Comp Biochem Physiol [A]"},{"key":"2023041302464026000_20.20.7782.17","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(85)90070-X"},{"key":"2023041302464026000_20.20.7782.18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0022-3565(24)37466-X","article-title":"Levels of endogenous adenosine in rat striatum. II. Regulation of basal and N-methyl-d-aspartate-induced levels by inhibitors of adenosine transport and metabolism.","volume":"285","author":"Delaney","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"2023041302464026000_20.20.7782.19","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(86)90189-8"},{"key":"2023041302464026000_20.20.7782.20","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(89)90617-4"},{"key":"2023041302464026000_20.20.7782.21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0022-510X(90)90023-G","article-title":"Changes in benzodiazepine and acetylcholine receptors in the globus pallidus in Parkinson's disease.","volume":"100","author":"Griffiths","year":"1990","journal-title":"J Neurol Sci"},{"key":"2023041302464026000_20.20.7782.22","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)11871-S"},{"key":"2023041302464026000_20.20.7782.23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(91)91673-O","article-title":"Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-d-aspartate receptor activation in rat nucleus accumbens and neostriatum.","volume":"566","author":"Henselmans","year":"1991","journal-title":"Brain Res"},{"key":"2023041302464026000_20.20.7782.24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0026-895X(25)08884-4","article-title":"2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.","volume":"41","author":"Hide","year":"1992","journal-title":"Mol Pharmacol"},{"key":"2023041302464026000_20.20.7782.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00694-5"},{"key":"2023041302464026000_20.20.7782.26","first-page":"13","article-title":"Brain monoamines and parkinsonism.","volume":"00","author":"Hornykiewicz","year":"1975","journal-title":"Natl Inst Drug Abuse Res Monogr Ser"},{"key":"2023041302464026000_20.20.7782.27","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.bjp.0701267","article-title":"Electrically-evoked dopamine and acetylcholine release from rat striatal slices perfused without magnesium: regulation by glutamate acting on NMDA receptors.","volume":"121","author":"Jin","year":"1997","journal-title":"Br J Pharmacol"},{"key":"2023041302464026000_20.20.7782.28","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430415"},{"key":"2023041302464026000_20.20.7782.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)00148-0"},{"key":"2023041302464026000_20.20.7782.30","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(19961028)374:4<578::AID-CNE7>3.0.CO;2-Z"},{"key":"2023041302464026000_20.20.7782.31","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410340413"},{"key":"2023041302464026000_20.20.7782.32","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199408000-00012"},{"key":"2023041302464026000_20.20.7782.33","first-page":"525","article-title":"The NMDA2B antagonist Ro 25-6981 is an anti-parkinsonian agent.","volume":"12","author":"Loschmann","year":"1997","journal-title":"Mov Disord"},{"key":"2023041302464026000_20.20.7782.34","doi-asserted-by":"publisher","DOI":"10.1007\/BF02259538"},{"key":"2023041302464026000_20.20.7782.35","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1994.1007"},{"key":"2023041302464026000_20.20.7782.36","unstructured":"Marsden CA Joseph SA (1989) HPLC of macromolecules: a practical approach. (IRL, Oxford)."},{"key":"2023041302464026000_20.20.7782.37","first-page":"125","article-title":"Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions.","volume":"7","author":"Menegoz","year":"1995","journal-title":"NeuroReport"},{"key":"2023041302464026000_20.20.7782.38","doi-asserted-by":"crossref","unstructured":"Miller WC DeLong MR (1987) Altered tomic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. in The basal ganglia II, eds Carpenter MB Jayaraman A (Plenum, New York), pp 415\u2013427.","DOI":"10.1007\/978-1-4684-5347-8_29"},{"key":"2023041302464026000_20.20.7782.39","first-page":"146","article-title":"Neural mechanisms in Parkinson's disease and related disorders.","volume":"2","author":"Mitchell","year":"1989","journal-title":"Drug News Perspect"},{"key":"2023041302464026000_20.20.7782.40","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(86)90013-3"},{"key":"2023041302464026000_20.20.7782.41","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(94)90052-3"},{"key":"2023041302464026000_20.20.7782.42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.18.8473"},{"key":"2023041302464026000_20.20.7782.43","first-page":"79.5","article-title":"Anti-Parkinsonian effect of NR2B-selective NMDA antagonists in animal models of Parkinson's disease: a striatal mechanism of action?","volume":"23","author":"Nash","year":"1997","journal-title":"Soc Neurosci Abstr"},{"key":"2023041302464026000_20.20.7782.44","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1998.6963"},{"key":"2023041302464026000_20.20.7782.45","doi-asserted-by":"crossref","unstructured":"Nash JE, Fox SH, Henry B, Hill MP, Peggs D, McGuire S, Maneuf Y, Hille C, Crossman AR, Brotchie JM 2000 Anti-parkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease. Exp Neurol, in press.","DOI":"10.1006\/exnr.2000.7444"},{"key":"2023041302464026000_20.20.7782.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)01049-X"},{"key":"2023041302464026000_20.20.7782.47","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)01121-X"},{"key":"2023041302464026000_20.20.7782.48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1985.tb07205.x"},{"key":"2023041302464026000_20.20.7782.49","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)90796-X"},{"key":"2023041302464026000_20.20.7782.50","unstructured":"Paxinos G Watson CP (1998) The rat brain in stereotaxic co-ordinates. (Academic, New York)."},{"key":"2023041302464026000_20.20.7782.51","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100606"},{"key":"2023041302464026000_20.20.7782.52","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(94)00130-K"},{"key":"2023041302464026000_20.20.7782.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1980.tb04625.x"},{"key":"2023041302464026000_20.20.7782.54","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870020201"},{"key":"2023041302464026000_20.20.7782.55","first-page":"S179","article-title":"Medical treatment of levodopa-induced dyskinesias.","volume":"474[Suppl 1]","author":"Rascol","year":"2000","journal-title":"Ann Neurol"},{"key":"2023041302464026000_20.20.7782.56","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.42.2.143"},{"key":"2023041302464026000_20.20.7782.57","first-page":"000","article-title":"Striatal NR2B NMDA receptor subunit expression is elevated following D2, but not D1 dopamine receptor antagonism in rat.","volume":"10","author":"Ravenscroft","year":"1998","journal-title":"Eur J Neurosci"},{"key":"2023041302464026000_20.20.7782.58","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90762-Z"},{"key":"2023041302464026000_20.20.7782.59","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)91545-C"},{"key":"2023041302464026000_20.20.7782.60","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(90)90066-J"},{"key":"2023041302464026000_20.20.7782.61","first-page":"65","article-title":"Behavioural pharmacology of glutamate in the basal ganglia.","volume":"38","author":"Schmidt","year":"1992","journal-title":"J Neural Transm [Suppl]"},{"key":"2023041302464026000_20.20.7782.62","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-12-08419.1995"},{"key":"2023041302464026000_20.20.7782.63","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(95)00035-6"},{"key":"2023041302464026000_20.20.7782.64","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1046\/j.1471-4159.1997.69031066.x","article-title":"M3 muscarinic receptor-mediated enhancement of NMDA-evoked adenosine release in rat cortical slices in vitro.","volume":"69","author":"Semba","year":"1997","journal-title":"J Neurochem"},{"key":"2023041302464026000_20.20.7782.65","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2000.7374"},{"key":"2023041302464026000_20.20.7782.66","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.4049\/jimmunol.145.5.1537","article-title":"Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface.","volume":"145","author":"Sullivan","year":"1990","journal-title":"J Immunol"},{"key":"2023041302464026000_20.20.7782.67","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(00)00930-7"},{"key":"2023041302464026000_20.20.7782.68","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.14-11-06317.1994"},{"key":"2023041302464026000_20.20.7782.69","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(68)90164-7"},{"key":"2023041302464026000_20.20.7782.70","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00001756-199211000-00007","article-title":"Elevated NMDA receptors in parkinsonian striatum.","volume":"3","author":"Weihmuller","year":"1992","journal-title":"NeuroReport"},{"key":"2023041302464026000_20.20.7782.71","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00084-2"},{"key":"2023041302464026000_20.20.7782.72","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0006-8993(86)91598-2","article-title":"Topographical distribution of amines and major amine metabolites in the rat striatum.","volume":"367","author":"Widmann","year":"1986","journal-title":"Brain Res"},{"key":"2023041302464026000_20.20.7782.73","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(92)90151-E"},{"key":"2023041302464026000_20.20.7782.74","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)90682-D"}],"container-title":["The Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1523\/JNEUROSCI.20-20-07782.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:48:25Z","timestamp":1751546905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jneurosci.org\/lookup\/doi\/10.1523\/JNEUROSCI.20-20-07782.2000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,15]]},"references-count":74,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2000,10,15]]},"published-print":{"date-parts":[[2000,10,15]]}},"alternative-id":["10.1523\/JNEUROSCI.20-20-07782.2000"],"URL":"https:\/\/doi.org\/10.1523\/jneurosci.20-20-07782.2000","relation":{},"ISSN":["0270-6474","1529-2401"],"issn-type":[{"value":"0270-6474","type":"print"},{"value":"1529-2401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10,15]]}}}